




Searching News Database: Infinity Pharmaceuticals
HSMN NewsFeed - 28 Mar 2022
Avenge Bio Appoints Claudio Dansky Ullmann, M.D., as Chief Medical Officer
Avenge Bio Appoints Claudio Dansky Ullmann, M.D., as Chief Medical Officer
HSMN NewsFeed - 5 Sep 2018
ArcherDX, Inc. Names Former Foundation Medicine Executive Steven Kafka, Ph.D. to its Board of Directors
ArcherDX, Inc. Names Former Foundation Medicine Executive Steven Kafka, Ph.D. to its Board of Directors
HSMN NewsFeed - 7 Aug 2018
Infinity Pharmaceuticals Appoints Samuel Agresta, M.D., M.P.H. as Chief Medical Officer
Infinity Pharmaceuticals Appoints Samuel Agresta, M.D., M.P.H. as Chief Medical Officer
HSMN NewsFeed - 1 Mar 2017
José Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems
José Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems
HSMN NewsFeed - 13 Jul 2016
Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
HSMN NewsFeed - 7 Dec 2015
Syros Pharmaceuticals Appoints David A. Roth, M.D., as Chief Medical Officer
Syros Pharmaceuticals Appoints David A. Roth, M.D., as Chief Medical Officer
HSMN NewsFeed - 3 Nov 2015
Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
HSMN NewsFeed - 14 Apr 2015
Infinity Augments Executive Leadership Team, Appointing Chief Commercial Officer and General Counsel
Infinity Augments Executive Leadership Team, Appointing Chief Commercial Officer and General Counsel
HSMN NewsFeed - 11 Apr 2011
Infinity Announces Appointment of Joshua Hamermesh as Vice President, Business and Corporate Development
Infinity Announces Appointment of Joshua Hamermesh as Vice President, Business and Corporate Development
HSMN NewsFeed - 5 Jan 2011
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
HSMN NewsFeed - 14 Oct 2010
Catabasis Pharmaceuticals Appoints Michael Curtis, Ph.D., as Vice President, Product Development
Catabasis Pharmaceuticals Appoints Michael Curtis, Ph.D., as Vice President, Product Development
HSMN NewsFeed - 23 Feb 2010
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer
HSMN NewsFeed - 28 Oct 2008
Infinity Announces the Promotion of Adelene Q. Perkins to President and Chief Business Officer
Infinity Announces the Promotion of Adelene Q. Perkins to President and Chief Business Officer
HSMN NewsFeed - 4 Feb 2008
Infinity and MedImmune Announce Approval for Generic Name for Novel Hsp90 Inhibitor
Infinity and MedImmune Announce Approval for Generic Name for Novel Hsp90 Inhibitor
HSMN NewsFeed - 5 Dec 2006
Ambit Biosciences Appoints Kerry Kelly, J.D., as Vice President and General Counsel
Ambit Biosciences Appoints Kerry Kelly, J.D., as Vice President and General Counsel
Additional items found! 6

Members Archive contains
6 additional stories matching:
Infinity Pharmaceuticals
(Password required)
Infinity Pharmaceuticals
(Password required)